The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early ...

Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic ...

The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring ...

AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.